Search

everythinglearnresearchcommunity

for

Search:↓

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

CD2 might be a new treatment target for patchy alopecia areata.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The document is a detailed medical reference on skin and genetic disorders.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Calcium signals and SHH guide the direction of feather growth in chicken skin.

Eating grape powder may reduce the severity of skin allergy symptoms.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Keratin protein production in cells is controlled by a complex system that changes with cell type, health, and conditions like injury or cancer.

Different types of skin fibroblasts have unique roles in skin health and disease.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

Four natural compounds were found to promote hair growth effectively.

New understanding and treatments for hair loss are improving, but more research is needed.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.